Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis.
Luís Silva MonteiroLorena Castro MarianoSaman WarnakulasuriyaPublished in: Oral diseases (2022)
The results of this SRMA support the role of podoplanin immunohistochemical expression as a potential predictive biomarker to assess the risk of malignancy development in oral leukoplakia.